These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29542882)

  • 1. Medicare Part D: Are Insurers Gaming the Low Income Subsidy Design?
    Decarolis F
    Am Econ Rev; 2015 Apr; 105(4):1547-80. PubMed ID: 29542882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The unintended effects of the Medicare Part D low income subsidy.
    Decarolis F
    Health Policy; 2015 May; 119(5):597-603. PubMed ID: 25716285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple change to the Medicare Part D low-income subsidy program could save $5 billion.
    Zhang Y; Zhou C; Baik SH
    Health Aff (Millwood); 2014 Jun; 33(6):940-5. PubMed ID: 24889942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare program; modification to the weighting methodology used to calculate the low-income benchmark amount. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Apr; 73(65):18176-82. PubMed ID: 18464346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual market health plan affordability after cost-sharing reduction subsidy cuts.
    Drake C; Abraham JM
    Health Serv Res; 2019 Aug; 54(4):730-738. PubMed ID: 31218670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Low-Income Subsidy Recipients Respond to Medicare Part D Cost Sharing.
    Stuart B; Hendrick FB; Xu J; Dougherty JS
    Health Serv Res; 2017 Jun; 52(3):1185-1206. PubMed ID: 27324201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affordability and adherence gains for Medicare Part D low-income subsidy recipients when low-income subsidy benefits expanded in 2024.
    Stuart BC; Loh FE; Dougherty JS
    J Manag Care Spec Pharm; 2024 Jul; 30(7):728-735. PubMed ID: 38950158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Medicare drug benefit: update on the low-income subsidy.
    Stahlman ME
    Issue Brief George Wash Univ Natl Health Policy Forum; 2009 Jul; (833):1-22. PubMed ID: 19685590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specialty Tier-Level Cost Sharing and Biologic Agent Use in the Medicare Part D Initial Coverage Period Among Beneficiaries With Rheumatoid Arthritis.
    Doshi JA; Hu T; Li P; Pettit AR; Yu X; Blum M
    Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1624-1630. PubMed ID: 27014854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsidizing Health Insurance for Low-Income Adults: Evidence from Massachusetts.
    Finkelstein A; Hendren N; Shepard M
    Am Econ Rev; 2019 Apr; 109(4):1530-67. PubMed ID: 30990593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions. Final rule with comment period.
    Fed Regist; 2009 Jan; 74(7):1493-549. PubMed ID: 19143114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans.
    Inquiry; 2004; 41(2):116-29. PubMed ID: 15449428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixing flaws in Medicare drug coverage that prompt insurers to avoid low-income patients.
    Hsu J; Fung V; Huang J; Price M; Brand R; Hui R; Fireman B; Dow WH; Bertko J; Newhouse JP
    Health Aff (Millwood); 2010 Dec; 29(12):2335-43. PubMed ID: 21030394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coverage for hepatitis C drugs in Medicare Part D.
    Jung JK; Feldman R; Cheong C; Du P; Leslie D
    Am J Manag Care; 2016 May; 22(6 Spec No.):SP220-6. PubMed ID: 27266952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare Part D subsidies. Final rules.
    Social Security Administration (SSA)
    Fed Regist; 2005 Dec; 70(250):77663-85. PubMed ID: 16392171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Larger Health Insurance Subsidies Benefit Patients or Producers? Evidence from Medicare Advantage.
    Cabral M; Geruso M; Mahoney N
    Am Econ Rev; 2018 Aug; 108(8):2048-87. PubMed ID: 30091862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pricing behaviour of nonprofit insurers in a weakly competitive social health insurance market.
    Douven RC; Schut FT
    J Health Econ; 2011 Mar; 30(2):439-49. PubMed ID: 21295365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eligibility and take-up of the Medicare Part D low-income subsidy.
    Shoemaker JS; Davidoff AJ; Stuart B; Zuckerman IH; Onukwugha E; Powers C
    Inquiry; 2012; 49(3):214-30. PubMed ID: 23230703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D.
    Wei II; Lloyd JT; Shrank WH
    J Am Geriatr Soc; 2013 Aug; 61(8):1315-23. PubMed ID: 23889465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using matched survey and administrative data to estimate eligibility for the Medicare Part D low-income subsidy program.
    Meijer E; Karoly LA; Michaud PC
    Soc Secur Bull; 2010; 70(2):63-82. PubMed ID: 20560303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.